225 related articles for article (PubMed ID: 26177320)
1. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
[TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
3. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.
de Krijger RR; Papathomas TG
Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150
[TBL] [Abstract][Full Text] [Related]
5. Pathological and molecular features of adrenocortical carcinoma: an update.
Volante M; Buttigliero C; Greco E; Berruti A; Papotti M
J Clin Pathol; 2008 Jul; 61(7):787-93. PubMed ID: 18430754
[TBL] [Abstract][Full Text] [Related]
6. A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A; Pakbaz S; Mete O
Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
[TBL] [Abstract][Full Text] [Related]
7. Challenges in surgical pathology of adrenocortical tumours.
Erickson LA
Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
[TBL] [Abstract][Full Text] [Related]
8. Application of Molecular Pathology in Endocrine Pathology.
Linke ES; Tezel GG
Turk Patoloji Derg; 2015; 31 Suppl 1():181-8. PubMed ID: 26177327
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma: review and update.
Erickson LA; Rivera M; Zhang J
Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
[TBL] [Abstract][Full Text] [Related]
10. A Case Report of Bilateral Sarcomatoid Carcinoma of Adrenal Glands With Adrenal Insufficiency.
Ishikawa N; Nagase M; Takami S; Araki A; Ishikawa N; Koike C; Shiina H; Maruyama R
Int J Surg Pathol; 2016 Dec; 24(8):743-748. PubMed ID: 27353077
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
[TBL] [Abstract][Full Text] [Related]
12. [Adrenocortical cancer: morphological variants, immunohistochemical characteristics].
Tkachuk AV; Tertychnyi AS; Beltsevich DG; Roslyakova AA; Belousov PV; Selivanova LS
Arkh Patol; 2021; 83(3):10-18. PubMed ID: 33822549
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.
Duregon E; Volante M; Giorcelli J; Terzolo M; Lalli E; Papotti M
Hum Pathol; 2013 May; 44(5):822-8. PubMed ID: 23158211
[TBL] [Abstract][Full Text] [Related]
14. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
Sasano H; Suzuki T; Moriya T
Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
[TBL] [Abstract][Full Text] [Related]
16. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know.
Ganeshan D; Bhosale P; Kundra V
AJR Am J Roentgenol; 2012 Dec; 199(6):1283-93. PubMed ID: 23169720
[TBL] [Abstract][Full Text] [Related]
17. Myxoid variant of adrenocortical carcinoma: report of a unique case.
Karim RZ; Wills EJ; McCarthy SW; Scolyer RA
Pathol Int; 2006 Feb; 56(2):89-94. PubMed ID: 16445821
[TBL] [Abstract][Full Text] [Related]
18. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
Mete O; Gucer H; Kefeli M; Asa SL
Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.
Mete O; Asa SL; Giordano TJ; Papotti M; Sasano H; Volante M
Endocr Pathol; 2018 Jun; 29(2):137-149. PubMed ID: 29542002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
